World Hepatitis Alliance

World Hepatitis Alliance
Name	World Hepatitis Alliance
Formation	2007
Type	Non-governmental organization
Headquarters	Geneva, Switzerland
Region served	Global
Leader title	President

World Hepatitis Alliance is an international non-governmental organization focused on the elimination of viral hepatitis as a public health threat. Founded by a consortium of patient groups and civil society advocates, the Alliance convenes coalitions, mobilizes campaigns, and engages with multilateral institutions to influence policy on hepatitis B and hepatitis C. It operates at intersections with global health institutions, patient organizations, and policy fora to catalyze national and international action.

History

The Alliance emerged from meetings among patient advocates and representatives from World Health Organization, Médecins Sans Frontières, Joint United Nations Programme on HIV/AIDS, Global Fund to Fight AIDS, Tuberculosis and Malaria, and regional NGOs in the mid-2000s. Key founding meetings included gatherings in Geneva and at international conferences such as the International Liver Congress and the World Health Assembly. Early milestones involved collaboration with the World Hepatitis Summit organizers and alignment with resolutions discussed within United Nations fora and the European Union health policy network. Over subsequent years the organization participated in advocacy that contributed to the adoption of the first global WHO Strategy on Viral Hepatitis and worked alongside national patient groups from countries including India, China, Brazil, South Africa, Russia, Egypt, and Pakistan to elevate hepatitis on national health agendas.

Mission and Objectives

The Alliance's mission centers on accelerating action to eliminate viral hepatitis, particularly hepatitis B and hepatitis C, by supporting affected communities, influencing policy, and strengthening civil society capacity. Objectives include promoting access to diagnostics and antiviral treatments championed at forums like the World Health Assembly, driving awareness campaigns concurrent with World Hepatitis Day, and ensuring inclusion of hepatitis responses in broader initiatives such as Sustainable Development Goals deliberations and Universal Health Coverage strategies debated within World Bank and United Nations meetings. The Alliance emphasizes empowerment of patient organizations such as those modeled on Hepatitis B Foundation and collaborates with clinical and research institutions like Centers for Disease Control and Prevention and National Institutes of Health.

Governance and Structure

The Alliance is structured as a membership-based federation incorporating patient groups, advocacy organizations, and professional societies. Its governance features an elected Board of Directors analogous to boards of Amnesty International and Red Cross and Red Crescent Movement, and an Executive Secretariat located in Geneva. Committees mirror models used by Global Health Council and International Hepato-Pancreato-Biliary Association to oversee campaigns, policy, and finance. Membership engagement pathways include regional focal points similar to those used by Pan American Health Organization, African Union health networks, and Asia-Pacific Economic Cooperation health dialogues. Leadership selection, strategic planning, and accountability measures are comparable to practices within Doctors Without Borders and Save the Children.

Global Campaigns and Programs

Major programs focus on awareness, testing, treatment access, and stigma reduction. Signature initiatives include global observances tied to World Hepatitis Day and targeted campaigns modeled after advocacy efforts like those of UNAIDS for HIV. The Alliance has coordinated testing drives, linkage-to-care projects, and hepatitis elimination roadmaps in partnership with national ministries of health in Egypt, Georgia, Iceland, and Australia. It provides capacity-building workshops similar to programs run by Clinton Health Access Initiative and technical guidance analogous to resources from World Hepatitis Summit collaborators. Campaigns also engage with pharmaceutical access mechanisms such as those influenced by Medicines Patent Pool negotiations and procurement frameworks used by Gavi, the Vaccine Alliance.

Partnerships and Funding

The Alliance partners with multilateral institutions, academic centers, philanthropic foundations, and industry stakeholders. Strategic partners have included World Health Organization, UNICEF, UNDP, and research institutions like London School of Hygiene & Tropical Medicine and Johns Hopkins University. Funding streams combine grants from foundations akin to Bill & Melinda Gates Foundation, project support from bilateral agencies such as UK Department for International Development and United States Agency for International Development, and contributions from corporate partners under controlled engagement policies similar to those of Global Fund. The Alliance also receives support through sponsored campaigns, membership dues, and collaborative grants with organizations like Hepatitis B Foundation and regional networks in Southeast Asia and Sub-Saharan Africa.

Impact and Advocacy Outcomes

The Alliance has contributed to measurable shifts in global hepatitis policy, advocacy visibility, and community mobilization. Its role in elevating viral hepatitis onto the World Health Assembly agenda influenced the adoption of WHO elimination targets and spurred national strategies in countries such as Georgia and Egypt. Awareness campaigns tied to World Hepatitis Day have expanded public and policymaker attention in conjunction with reporting from outlets that cover global health summits like the International AIDS Conference. Collaborative initiatives have facilitated expanded access to direct-acting antivirals in pilot programs and increased screening efforts modeled on successful public health campaigns such as those used against HIV/AIDS. The Alliance's convening power continues to support civil society participation in high-level meetings including United Nations General Assembly health dialogues and regional health ministerial conferences.

Category:International medical and health organizations Category:Non-governmental organizations